Done sou Salè H1B

Akèy › Vil › California › South San Francisco

Pwonse H-1B nan South San Francisco, CA

Anplwayè yo te depoze 2,874 aplikasyon kondisyon travay pou travay nan South San Francisco, CA pandan ane fiskal 2023–2026. Salè baz medyàn ofri: $145,286.

Demann (LCA)2,874
Salè medyan ofri$145,286
Mwatye salè yo$120,292–$175,000
10yèm–90yèm pousantaj$101,802–$206,315

Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →

Pi gwo pwonse yo

AnplwayèLCASalè medyan
Genentech, Inc.443$141,500
Stripe, Inc.279$181,272
ZS Associates, Inc.182$170,000
Zipline International Inc.174$165,939
Amgen Inc.96$135,000
Genentech USA, Inc.90$159,328
Abbvie Biotherapeutics Inc.72$143,000
Verily Life Sciences LLC63$162,000
Insitro, Inc.48$120,000
Twist Bioscience Corporation48$149,375
Calico Life Sciences LLC46$159,500
Thermo Fisher Scientific Inc.45$138,320
Denali Therapeutics Inc.36$140,000
Tech Mahindra (americas), Inc35$132,871
Saama Technologies, LLC31$135,000
MRL San Francisco, LLC28$125,040
AbbVie Inc.26$147,000
Sana Biotechnology, Inc.25$135,000
Tata Consultancy Services Limited23$105,040
Cytokinetics, Inc.21$131,000
Incedo, Inc.21$139,589
ProcDNA, LLC21$125,817
Blue Matter Consulting LLC19$130,000
Ernst & Young U.S. LLP18$154,961
Veracyte, Inc.18$135,200
Sutro Biopharma, Inc.17$162,137
AeroVect Technologies Inc17$173,250
Freenome Holdings, Inc.16$176,000
Ideaya Biosciences Inc.15$152,984
Eli Lilly and Company14$144,740
Cigniti Technologies, Inc.14$110,682
GlaxoSmithKline LLC13$181,813
Senti Biosciences, Inc.13$124,407
DGN Technologies, Inc13$132,435
AstraZeneca Pharmaceuticals LP11$157,669
Infosys Limited11$148,450
Pfizer Inc.11$127,774
Persistent Systems, Inc.10$113,682
CitiusTech Inc.10$116,500
Maze Therapeutics Inc.10$131,650
Diamond Foundry Inc9$160,000
Arsenal Biosciences, Inc.9$140,000
Mission Bio, Inc.9$107,702
Plenty Unlimited, Inc.8$129,500
Mytra, Inc.8$160,540
NGM Biopharmaceuticals, Inc.8$112,550
Nkarta, Inc.8$138,362
Soley Therapeutics, Inc8$150,000
Jeeva AI, Inc.8$120,000
CytomX Therapeutics, Inc.7$127,000
Vaxart, Inc.7$124,800
Zifo Technologies, Inc7$92,000
Alector LLC6$153,588
Lyell Immunopharma, Inc.6$163,506
Magnit, LLC6$110,240
AKASA, Inc.6$167,710
RAPT Therapeutics, Inc. (Formerly FLX Bio, Inc.)6$187,908
Lyterian Therapeutics6$138,000
Deloitte & Touche LLP6$79,456
AbbVie US LLC6$154,564

Oksipasyon

Tit travay

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).